Psynerva Pharmaceuticals Private Limited
About Psynerva Pharmaceuticals Private Limited
Data last updated:
Psynerva Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 26 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24232BR2013PTC021713. Its GSTIN is 10AAHCP5536E1ZS (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Archana Saurav and Prasanna Jee Sahay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Shri Onkar Nath Sahay Hari Om Sadan Road No – 3 B R.M.S Colony Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.88 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹51,491 (net margin 5.2%) and EBITDA of ₹65,087 (EBITDA margin 6.6%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Psynerva Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Shri Onkar Nath Sahay Hari Om Sadan Road No – 3 B R.M.S Colony Kankarbagh, Patna, Bihar, India – 800020
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Psynerva Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Psynerva Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Psynerva Pharmaceuticals Private Limited, buy the company report.
Financials of Psynerva Pharmaceuticals Private Limited
FY 2025 filings availablePsynerva Pharmaceuticals Private Limited reported revenue of ₹9.88 Lakh (up 52% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 52% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹65,087 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51,491 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Psynerva Pharmaceuticals Private Limited, buy the company report.
Board of directors of Psynerva Pharmaceuticals Private Limited
Psynerva Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Saurav | Director | 08 Feb 2021 | 5 Years 8 Months | Current |
| Prasanna Jee Sahay | Director | 26 Dec 2013 | 12 Years 9 Months | Current |
Peer comparison
Psynerva Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reydis Pharmaceuticals Private Limited | ₹9.93 Lakh (FY 2025) | Tijara, Rajasthan, India | ||||
| Columbine Pharmaceuticals Private Limited | ₹9.9 Lakh (FY 2024) | 277.0% | Burdwan, West Bengal, India | |||
| Psynerva Pharmaceuticals Private Limitedthis company | ₹9.88 Lakh (FY 2024) | ₹51,491 | 5.2% | 52.0% | Patna, Bihar, India | |
| Maclave Pharmaceuticals Private Limited | ₹9.78 Lakh (FY 2024) | 24.0% | Etawah, Uttar Pradesh, India |
To see the full peer comparison of Psynerva Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Psynerva Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Psynerva Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Psynerva Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Psynerva Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Psynerva Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCP5536E1ZS | Bihar | Active | 13 Jul 2017 |
To see the full GST registrations and return filing status of Psynerva Pharmaceuticals Private Limited, buy the company report.
Recent activity
Psynerva Pharmaceuticals Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Mukundjee Sahay ceased to be Director on 22 Aug 2024.
Frequently asked questions
Psynerva Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 26 December 2013 (13+ years old) and is registered under CIN U24232BR2013PTC021713.
Psynerva Pharmaceuticals has 2 current directors:
- Archana Saurav - Director
- Prasanna Jee Sahay - Director
The latest financial statements of Psynerva Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Psynerva Pharmaceuticals is 10AAHCP5536E1ZS, registered in Bihar.
The CIN (Corporate Identification Number) of Psynerva Pharmaceuticals is U24232BR2013PTC021713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Psynerva Pharmaceuticals was incorporated on 26 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Psynerva Pharmaceuticals by revenue are Reydis Pharmaceuticals Private Limited, Columbine Pharmaceuticals Private Limited, Maclave Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mukundjee Sahay ceased to be Director on 22 Aug 2024. Rohit ceased to be Director on 24 Feb 2021. Archana Saurav was appointed as Director on 08 Feb 2021. Psynerva Pharmaceuticals has 5 board changes on record in total.
The registered office of Psynerva Pharmaceuticals is at CO Shri Onkar Nath Sahay Hari Om Sadan Road No – 3 B R.M.S Colony Kankarbagh, Patna, Bihar, India – 800020.
Psynerva Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Psynerva Pharmaceuticals is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.